Visible Genetics to launch p53 cancer gene test for research use later this month.
This article was originally published in The Gray Sheet
Executive Summary
VISIBLE GENETICS TO LAUNCH P53 CANCER GENE TEST FOR RESEARCH USE this month, the company says. The test is based on the Toronto, Canada firm's proprietary Clip "single-tube" DNA sequencing technology. Visible Genetics plans eventually to commercialize the p53 test as well as Clip-based diagnostics for infectious disease.